Clinical trial
Pre TAVI Membranous Septum Measurement Predicts High Grade Iatrioventricular Conduction Disorders in Patients With Specific Pacemaker Implanted After TAVI. The STIM TAVI-MS Study
NCT04906837 is registered in ClinicalTrials.gov with Association de Recherche en Cardiologie des Alpes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pre TAVI Membranous Septum Measurement Predicts High Grade Iatrioventricular Conduction Disorders in Patients With Specific Pacemaker Implanted After TAVI. The STIM TAVI-MS Study
- Lead sponsor
- Association de Recherche en Cardiologie des Alpes
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 20, 2020
- Completion date
- February 26, 2021
- Enrollment
- 197 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
conduction disturbance, trans aortic valve implantation (tavi)